Metastatic Solid Tumors Clinical Trials

75 clinical trials for Metastatic Solid Tumors across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SLR-108 PET Imaging in Subjects With Metastatic Solid Tumors — RECRUITING · PHASE1
• BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) — RECRUITING · PHASE1
• Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors — RECRUITING · PHASE1
• A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers — RECRUITING · PHASE1
• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — RECRUITING · PHASE1
• The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. — RECRUITING · NA
• Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors — RECRUITING · PHASE1
• AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) — RECRUITING · PHASE1
• A Study of SKB107 in Advanced Solid Tumors With Bone Metastases — RECRUITING · PHASE1
• SLV-324 Treatment of Metastatic Solid Tumors — RECRUITING · PHASE1
• Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of DS3610a in Participants With Advanced Solid Tumor — RECRUITING · PHASE1
• A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors. — RECRUITING · PHASE1
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — RECRUITING · PHASE1
• Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of IOV-5001 in Adults With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Phase I Study of SM2275 Injection in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors. — NOT_YET_RECRUITING · NA
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification — TERMINATED · PHASE1
• A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01) — ACTIVE_NOT_RECRUITING · PHASE2
• Exploratory Clinical Study of ¹⁷⁷Lu-CTR-FAPI in Patients With Metastatic Solid Tumors — COMPLETED · PHASE1
• First in Human Study of M6223 — COMPLETED · PHASE1
• NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies — ACTIVE_NOT_RECRUITING · PHASE2
• Study of QLS5308 in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours — COMPLETED · PHASE2
• Image-Guided 125I Seed Implantation Plus Standard Systemic Therapy for Patients With Multiple Metastatic Lesions — NOT_YET_RECRUITING · PHASE2
• Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2) — NOT_YET_RECRUITING · PHASE1
• Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06 — COMPLETED · PHASE1
• Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers — COMPLETED · PHASE1
• Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases — NOT_YET_RECRUITING · PHASE1
• A Phase 2 Open-Label Study of Sacituzumab Govitecan (IMMU-132) in Subjects with Metastatic Solid Tumors — TERMINATED · PHASE2
• A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study — COMPLETED
• Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET — ACTIVE_NOT_RECRUITING · PHASE1
• Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy — COMPLETED · PHASE4
• 90-Day Mortality After Emergency Department Discharge in Advanced Cancer — COMPLETED
• First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors — COMPLETED · PHASE1
• A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors — COMPLETED · PHASE1
• A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors — NOT_YET_RECRUITING
• Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors — COMPLETED · PHASE1
• A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors — TERMINATED · PHASE1
• Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer — TERMINATED · PHASE1
• A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway — NOT_YET_RECRUITING · PHASE1

Refine this search